Independent Research & Data
From Cells to Society: Need for Research on Safety and Effectiveness
The open and ongoing debate on the safety and effectiveness of stun device usage has run the gamut from public safety to civil rights concerns.
With a dearth of available research, safety testing methodologies and standard measurement protocols, operators have been left with little guidance and direction on how to deploy intermediate force options as alternatives to lethal force that ensure the highest safety and effectiveness.
While a market need emerged for new technology, there was also an urgent demand for comprehensive health effects studies in order to prevent unintended consequences resulting from the use of this new technology.
In response, Aegis embarked on an R&D initiative called “Cells to Society” to support new advancements in NeuroMuscular Incapacitation (NMI) technology with the goal of furthering knowledge, understanding and guidelines for safe deployment of this technology.
By assembling a cross-disciplinary team of participants from the academic, military, government, and private sectors, the “Cells to Society” program linked knowledge from cellular mechanisms, efficacy and health effects to the implications of NMI use-of-force across populations, culture human rights and civil rights.
The rigorous R&D program produced high-quality, independent and peer-reviewed research covering cellular mechanisms using silico models, organismic responses to advanced waveforms, innovative hard and software integration, new perspectives on technology training and a broader focus on human and civil rights.
The resulting research served as the basis for Aegis’ Non-Invasive Neuromuscular Incapacitation™ (NINMI) technology and has been independently peer-reviewed and published in several separate professional journals, including:
- Military Medicine
- Journal of Surgical Research
- The Journal for Trauma Injury, Infection and Critical Care
- Abstract: Journal of Trauma, Injury, Infection and Critical Care
To obtain copies of our independent research studies, please contact us.
